Search research articles
Contact Us
Filters
Showing results (81-90 of 272) with videos related to
Page
of 28
Sort By:
BMC Cancer
|
July 26, 2006
Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma
Ciro Gallo, Ermelinda De Maio, Massimo Di Maio, et al.
World Journal of Gastroenterology
|
March 20, 2008
Is human hepatocellular carcinoma a hormone-responsive tumor?
Massimo Di Maio, Bruno Daniele, Sandro Pignata, et al.
Biomolecules
|
March 28, 2026
Selective Silencing of TDP-43 P. G376D Mutation Reverses Key Amyotrophic Lateral Sclerosis-Related Cellular Deficits
Roberta Romano, Giorgia Ruotolo, Francesco Perrone, et al.
Tumori
|
March 10, 2010
Off-label prescription of antineoplastic drugs: an Italian prospective, observational, multicenter survey
Fausto Roila, Enzo Ballatori, Roberto Labianca, et al.
Frontiers in Pharmacology
|
November 4, 2021
The Standard of Care Definitions on COVID-19 Pharmacological Clinical Trials: A Systematic Review
Antonio Addis, Laura Amato, Fabio Cruciani, et al.
The Oncologist
|
December 7, 2007
First-line chemotherapy for HER-2 negative metastatic breast cancer patients who received anthracyclines as adjuvant treatment
Alessandro Morabito, Maria Carmela Piccirillo, Katia Monaco, et al.
Expert Opinion on Drug Safety
|
March 31, 2010
Vinorelbine for non-small cell lung cancer
Maria Carmela Piccirillo, Gennaro Daniele, Massimo Di Maio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2007
Individual patient data meta-analysis of docetaxel administered once every 3 weeks compared with once every week second-line treatment of advanced non-small-cell lung cancer
Massimo Di Maio, Francesco Perrone, Paolo Chiodini, et al.
Journal of Medical Ethics
|
June 13, 2015
Time required to start multicentre clinical trials within the Italian Medicine Agency programme of support for independent research
Gianfranco De Feo, Luciano Frontini, Silvia Rota, et al.
Expert Opinion on Investigational Drugs
|
August 5, 2014
Vandetanib as a potential treatment for breast cancer
Antonella De Luca, Amelia D'Alessio, Monica Rosaria Maiello, et al.
Page
of 28
Search research articles
Search
Showing results (81-90 of 272) with videos related to
Sort By:
Page
of 28
BMC Cancer
|
July 26, 2006
Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma
Ciro Gallo, Ermelinda De Maio, Massimo Di Maio, et al.
World Journal of Gastroenterology
|
March 20, 2008
Is human hepatocellular carcinoma a hormone-responsive tumor?
Massimo Di Maio, Bruno Daniele, Sandro Pignata, et al.
Biomolecules
|
March 28, 2026
Selective Silencing of TDP-43 P. G376D Mutation Reverses Key Amyotrophic Lateral Sclerosis-Related Cellular Deficits
Roberta Romano, Giorgia Ruotolo, Francesco Perrone, et al.
Tumori
|
March 10, 2010
Off-label prescription of antineoplastic drugs: an Italian prospective, observational, multicenter survey
Fausto Roila, Enzo Ballatori, Roberto Labianca, et al.
Frontiers in Pharmacology
|
November 4, 2021
The Standard of Care Definitions on COVID-19 Pharmacological Clinical Trials: A Systematic Review
Antonio Addis, Laura Amato, Fabio Cruciani, et al.
The Oncologist
|
December 7, 2007
First-line chemotherapy for HER-2 negative metastatic breast cancer patients who received anthracyclines as adjuvant treatment
Alessandro Morabito, Maria Carmela Piccirillo, Katia Monaco, et al.
Expert Opinion on Drug Safety
|
March 31, 2010
Vinorelbine for non-small cell lung cancer
Maria Carmela Piccirillo, Gennaro Daniele, Massimo Di Maio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2007
Individual patient data meta-analysis of docetaxel administered once every 3 weeks compared with once every week second-line treatment of advanced non-small-cell lung cancer
Massimo Di Maio, Francesco Perrone, Paolo Chiodini, et al.
Journal of Medical Ethics
|
June 13, 2015
Time required to start multicentre clinical trials within the Italian Medicine Agency programme of support for independent research
Gianfranco De Feo, Luciano Frontini, Silvia Rota, et al.
Expert Opinion on Investigational Drugs
|
August 5, 2014
Vandetanib as a potential treatment for breast cancer
Antonella De Luca, Amelia D'Alessio, Monica Rosaria Maiello, et al.
Page
of 28